Myricetin protects against doxorubicin-induced liver damage by modulating oxidative and inflammatory pathways
Abstract Background Doxorubicin (Dox) is a highly effective chemotherapy drug used to treat various cancers. However, its clinical application is limited by liver toxicity, which is mainly caused by oxidative stress, inflammation, and mitochondrial damage. Myricetin, a natural flavonoid present in m...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2026-01-01
|
| Seri Bilgileri: | BMC Pharmacology and Toxicology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s40360-026-01088-1 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|